A postdoctoral position is available in Tumor Virus RNA Biology Section, RNA Biology Laboratory, Center for Cancer Research, National Cancer Institute, to investigate gene expression and post-transcriptional regulation of Kaposi sarcoma-associated herpesvirus (KSHV) and papillomaviruses. We are studying protein-RNA interactions in KSHV and papillomavirus infections as well as the mechanisms of noncoding RNA expression in regulation of tumor virus gene expression and viral oncogenesis. Experimental approaches include genetic studies in living cells and animals together with biochemical and next-generation sequencing (NGS) approaches, including CLIP-seq, RCA-seq, RNA-seq, microarray profiling, ribosome profiling, cDNA library construction, protein biochemistry, protein-RNA complex purification, transient/stable transfection, reporter assays, site-directed mutagenesis, real-time PCR, in vitro transcription and RNA splicing, RNA interference, proteomics, confocal microscopy, and flow cytometry, CRISPR/Cas9 technology, etc.
Candidates must have a Ph.D. and/or M.D. with less than 3 years of postdoctoral experience. Training/experience in virology, RNA biology, cell biology, molecular biology or genetics is required. Experience with RNA research is a strong plus.
Program duration is initially for 2 years, but might be extendable for a longer term. The stipend starts at $51,800, commensurate with experience.
Interested candidates should submit a cover letter, curriculum vitae, bibliography, and three letters of references before Jan. 30, 2017 to:
Dr. Zhi-Ming Zheng
Tumor Virus RNA Biology Section
RNA Biology Laboratory
National Cancer Institute-Frederick
Building 539, Room 152J
P.O. Box B
Frederick, MD 21702-1201
E-mail to zhengtexchange.nih.gov
Web site: https://ccr.cancer.gov/zhi-ming-zheng
This position is subject to a background investigation. The NIH is dedicated to building a diverse community in its training and employment programs. DHHS, NIH, and NCI are Equal Opportunity Employers